Goldline Pharmaceutical Appoints M/s Avinash Gandhewar & Associates as Secretarial Auditor
Goldline Pharmaceutical Ltd has appointed M/s Avinash Prakash Gandhewar, practicing Company Secretaries, as the company's Secretarial Auditor. The Board of Directors approved this appointment at a meeting held on July 14, 2026.The appointment is for the financial year spanning from April 1, 2025, until March 31, 2026.
M/s Avinash Gandhewar & Associates was selected to conduct the Secretarial Audit for the specified period. The company provided a detailed profile of the appointed firm, outlining its expertise and terms of engagement.
Key details regarding the appointment are as follows:
| Particulars | Details |
|---|---|
| Name of Auditor | M/s Avinash Gandhewar & Associates |
| Role | Secretarial Auditor |
| Financial Year Covered | 2025-26 |
| Date of Appointment | July 14, 2026 (Board meeting) |
| Field of Experience | Company Law, Securities Laws, Legal Due Diligence, Joint Ventures, FEMA, Public Offering (SME IPO), Mergers and Acquisitions, and NCLT matters. |
M/s Avinash Gandhewar & Associates is a Peer Reviewed Firm based in Nagpur. The terms of appointment involve conducting the Secretarial Audit for the financial year 2025-26.
Stock Price Movement
Goldline Pharmaceutical Ltd settled on Tuesday at ₹38.84, after shares slipped 3.84%. The stock navigated its trading range, dipping as low as ₹38.84 and reaching a high of ₹40.28.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.